Even if your appetite is diminished, try consuming easily digestible foods such as plain crackers, toast, or bananas every 23 hours
Building Your GLP-1 Relief Kit Managing your health journey doesn't have to be miserable
LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial Multi-receptor agonists that target the glucagon, glucose-dependent insulinotropic polypeptide (GIP), and glucagon-like peptide 1 (GLP-1) receptors may improve outcomes in type 2 diabetes because this condition is linked to hyperglycemia and obesity
Women with polycystic ovary syndrome were twice as likely to conceive, suggesting that weight loss may improve fertility, even when unintended
Electrolyte depletion sneaks up on people because it happens gradually
According to King Law: The lawsuits primarily allege that manufacturers like Novo Nordisk (maker of Wegovy) failed to adequately warn patients and healthcare providers about the risks associated with these drugs, such as severe gastrointestinal complications like gastroparesis (stomach paralysis), ileus (intestinal obstruction), and recently, vision loss due to non-arteritic anterior ischemic optic neuropathy (NAION). Prediction 2: More Emergency Room Visits Due to Adverse Effects In April 2025, Annals of Medicine reported that nearly 25,000 emergency room visits had occurred due to semaglutide adverse events in the years 2022 and 2023
